Meningiomas are the most common benign intracranial tumors, and in individuals ages 35 and older, the most common type of brain tumor diagnosed. They most often occur in people between the ages of 40 and 70. They originate from cells (arachnoid cap cells) within the arachnoid, a thin, spider web-like ...

At the 2011 American Association of Neurological Surgeons (AANS) Annual Meeting, April 9-13 at the Colorado Convention Center, Elekta (booth #1717) will highlight characteristics of Leksell Gamma Knife® Perfexion™ that separate the system from other radiosurgery solutions.

The volume of normal brain tissue exposed to radiation during treatment for multiple metastases appears to depend on which stereotactic radiosurgery system is employed, according to a recent study in the Journal of Neurosurgery(1). Comparing treatment plans developed for use by three different treatment systems for a single patient (already ...

For patients with extremely severe -compulsive disorder (OCD), a procedure called radiosurgery may bring improvement when other treatments have failed, according to a study in the January issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of ...

Patients report decreased pain and improved breathing following treatment of their hilar tumors with robotic radiosurgery, but researchers say the therapy falls short of improving survival. Still, the study, conducted by researchers at Georgetown Lombardi Comprehensive Cancer Center and presented today at the annual meeting of the American College ...

Accuray Incorporated, a global leader in the field of radiosurgery, announced today studies underway at two leading academic institutions using CyberKnife radiosurgery in breast cancer treatment. These two studies, from the University of Texas Southwestern and Fox Chase Cancer Center, will be presented at the 52nd Annual Meeting of the ...

SUNNYVALE, Calif., Oct. 31 /- Accuray Incorporated, (Nasdaq:  ARAY), a global leader in the field of radiosurgery, announced today studies underway at two leading academic institutions using CyberKnife radiosurgery in breast cancer treatment. These two studies, from the University of Texas Southwestern and Fox Chase Cancer Center, will be presented ...

Varian Medical Systems, Inc. today announced that CURE Foundation has placed an order for five Varian TrueBeam™ systems for stereotactic radiosurgery and radiation therapy.

TAIPEI, Taiwan, Oct. 14 /- Varian Medical Systems, Inc. (NYSE: VAR ), the world's leading manufacturer of medical technology for treating cancer with radiotherapy and radiosurgery, is introducing its new TrueBeam™ medical linear accelerator for the first time to clinicians in Asia at the 10th annual meeting of ...

SUNNYVALE, Calif., Oct. 6 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that the 100,000th patient has been treated with the CyberKnife ® Robotic Radiosurgery System, a non-invasive alternative to surgery for the treatment of both cancerous and non-cancerous ...

SUNNYVALE, Calif., Sept. 17 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that for the first time in Europe the company showcased its latest offering, the CyberKnife VSI System, at ESTRO 29; the Annual Congress of the European Society for ...

There is yet no straightforward way to determine the optimal dose level and treatment schedules for high-dose radiation therapies such as stereotactic radiation therapy, used to treat brain and lung cancer, or for high-dose brachytherapy for prostate and other cancers.